Region:Asia
Author(s):Geetanshi
Product Code:KRAA0607
Pages:97
Published On:January 2026

By Type:

The market is segmented into three types: Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics. Among these, Predictive Analytics is currently the leading sub-segment, driven by its ability to forecast patient outcomes and optimize treatment plans. The increasing reliance on data-driven decision-making in healthcare has led to a surge in demand for predictive models that can analyze vast datasets to identify trends and improve patient care. As healthcare providers seek to enhance operational efficiencies and patient satisfaction, the adoption of predictive analytics continues to rise.
By Component:

This segmentation includes Software and Services. The Software sub-segment is leading the market, primarily due to the increasing demand for advanced analytics tools that facilitate data processing and visualization. As healthcare organizations strive to improve their data management capabilities, the need for sophisticated software solutions has become paramount. Additionally, the rise of cloud-based software solutions has made it easier for organizations to adopt and integrate these technologies into their existing systems.
The Vietnam AI Life Science Analytics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IQVIA, Oracle, Accenture, Cognizant, Wipro, Thermo Fisher Scientific, Illumina, Invitae, Siemens Healthineers, SAP, Infosys, FujiFilm, VinBigData, FPT Corporation, Viettel Group contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Vietnam AI life science analytics market appears promising, driven by technological advancements and increasing healthcare demands. In future, the integration of AI in diagnostics and treatment planning is expected to enhance patient outcomes significantly. Furthermore, the expansion of telemedicine services will facilitate remote patient monitoring, allowing for real-time data analytics. As the government continues to support healthcare innovation, collaboration between tech companies and healthcare providers will likely accelerate the adoption of AI solutions, transforming the healthcare landscape.
| Segment | Sub-Segments |
|---|---|
| By Type | Descriptive Analytics Predictive Analytics Prescriptive Analytics |
| By Component | Software Services |
| By Delivery Model | On-Demand On-Premises |
| By Application | Research and Development Sales and Marketing Regulatory Compliance Supply Chain Analytics Pharmacovigilance |
| By End-User | Pharmaceutical and Biotechnology Companies Medical Device Companies Academic Institutions and Research Organizations Contract Research Organizations |
| By Region | Northern Vietnam Central Vietnam Southern Vietnam |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Healthcare AI Applications | 150 | Healthcare Administrators, AI Specialists |
| Biotechnology Research and Development | 100 | Biotech Researchers, Lab Managers |
| Pharmaceutical AI Integration | 80 | Pharmaceutical Executives, Data Analysts |
| Clinical Data Analytics | 70 | Clinical Researchers, Data Scientists |
| AI in Diagnostics | 90 | Diagnostic Lab Managers, Medical Technologists |
The Vietnam AI Life Science Analytics Market is valued at approximately USD 85 million, reflecting significant growth driven by the adoption of AI technologies in healthcare, personalized medicine demand, and increased healthcare expenditure in the region.